Barry Investment Advisors, LLC Viatris Inc Transaction History

Barry Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $226,061 - $354,877	-23,044 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $17,651 - $21,432	-1,460 Reduced 5.96%	23,044 $312,000
Q3 2021 Oct 29, 2021	SELL	$13.25 - $15.13 $4,849 - $5,537	-366 Reduced 1.47%	24,504 $332,000
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $11,206 - $13,953	-864 Reduced 3.36%	24,870 $355,000
Q1 2021 Apr 19, 2021	SELL	$13.59 - $18.54 $18,482 - $25,214	-1,360 Reduced 5.02%	25,734 $360,000
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $387,444 - $507,741	27,094 New	27,094 $508,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Barry Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Barry Investment Advisors, LLC with notifications on news.